|
Dr. Daniel J. Rader is the Cooper-McClure Professor of Medicine, Pathology, and Pharmacology at the University of Pennsylvania School of Medicine in Philadelphia, Pennsylvania, where he is Director of Preventive Cardiology, Director of the Lipid/Atherosclerosis Research Unit, Director of the General Clinical Research Center, and Associate Director of the Institute for Translational Medicine and Therapeutics. Dr. Rader runs a basic research laboratory focused on genetic regulation of lipoprotein metabolism and atherosclerosis and directs a clinical research program focused on human genetics of lipid disorders and atherosclerosis and novel approaches to the treatment of dyslipidemia and regression of atherosclerosis. He is a recipient of the Burroughs Wellcome Fund Clinical Scientist Award in Translational Research, a recipient of the Doris Duke Foundation Distinguished Clinical Scientist Award, and a recipient of the Bristol Myers Squibb Freedom to Discover Unrestricted Cardiovascular Research Award. Dr Rader is on the editorial boards of Arteriosclerosis Thrombosis and Vascular Biology, American Journal of Physiology (Endocrinology and Metabolism), Circulation, Circulation Research, Journal of Lipid Metabolism, and Trends in Molecular Medicine and is a reviewer for many journals, including Nature, Nature Medicine, Science, New England Journal of Medicine, and Journal of Clinical Investigation. Dr Rader has authored over 220 peer-reviewed publications and reviews and book chapters, including chapters on lipoprotein disorders for Harrison's Principles of Internal Medicine, Topol's Textbook of Cardiovascular Medicine, and Nelson's Textbook of Pediatrics.
| 